3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
44
Neoplasms
43
Lung Neoplasms
28
Colorectal Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Prostatic Neoplasms
15
Ovarian Neoplasms
15
Pancreatic Neoplasms
13
Melanoma
11
Uterine Cervical Neoplasms
10
Neoplastic Cells, Circulating
9
Neoplasm Metastasis
9
Sarcoma
8
Multiple Myeloma
8
Head and Neck Neoplasms
8
Glioma
8
Glioblastoma
8
Hematologic Neoplasms
7
Colonic Neoplasms
7
Carcinoma, Hepatocellular
7
Lymphoma
6
Leukemia, Myeloid, Acute
6
Endometrial Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Gastrointestinal Neoplasms
5
Disease
5
Brain Neoplasms
5
Urinary Bladder Neoplasms
4
Rectal Neoplasms
4
Peritoneal Neoplasms
4
Interventions
Valganciclovir
2
Valacyclovir
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Immunologic Techniques
1
Ganciclovir
1
Flow Cytometry
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Cytomegalovirus Infections
×
Blood Specimen Collection
×
Clear all
NCT03806764
2023-06-01
CReSCT
Melbourne Health
Phase NA
Unknown
370 enrolled